The putative excitatory transmitters glutamate and aspartate, as well as their excitatory analogues, can kill neurones in the central nervous system and may thus be involved in the pathogenesis of various neurodegenerative disorders1. Several studies have suggested that postsynaptic receptors are important in the mechanism of toxicity2. However, presynaptic factors might also be involved because, in some brain areas, the neurotoxicity of kainate (a potent structural analogue of glutamate) is greatly reduced following elimination of afferent excitatory innervation3–6, even though the postsynaptic excitatory potency of kainate may be unaltered in these conditions7. The supply of glutamate from the afferent nerve endings has been suggested to be a necessary factor3,6,8. Recently, Ferkany, Zaczec and Coyle9 concluded from studies on slices of mouse cerebellum that kainate activates presynaptic kainate receptors on parallel fibre terminals to release glutamate and that it is the postsynaptic interaction between kainate and the released amino acid that is instrumental in causing neuronal necrosis. The more direct evidence we report here does not support these conclusions.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Coyle, J. T. et al. Neurosci. Res. Prog. Bull. 19, 329–427 (1981).
Olney, J. W. in Kainic Acid as a Tool in Neurobiology (eds McGeer, E. G., Olney, J. W. & McGeer, P. L.) 95–121 (Raven, New York, 1978).
Biziere, K. & Coyle, J. T. Neurosci. Lett. 8, 303–310 (1978).
McGeer, E. G., McGeer, P. L. & Singh, K. Brain Res. 139, 381–383 (1978).
Kohler, C., Schwarcz, R. & Fuxe, Neurosci. Lett. 10, 241–246 (1978).
Streit, P., Stella, M. & Cuenod, M. Brain Res. 187, 45–57 (1980).
McLennan, H. Neurosci. Lett. 18, 313–316 (1980).
McGeer, E. G. & McGeer, P. L. Int. Rev. Neurobiol. 22, 173–204 (1981).
Ferkany, J. W., Zaczec, R. & Coyle, J. T. Nature 298, 757–759 (1982).
Garthwaite, J., Woodhams, P. L., Collins, M. J. & Balazs, R. Brain Res. 173, 373–377 (1979).
Garthwaite, J. & Wilkin, G. P. Neuroscience 7, 2499–2514 (1982).
Okamoto, K. & Quastel, J. H. Proc. R. Soc. B 184, 83–90 (1973).
Garthwaite, J. & Gilligan, G. J. Neuroscience (in the press).
Ferkany, J. W. & Coyle, J. T. J. Pharmac. exp. Ther. 255, 399–406 (1983).
Krespan, B., Berl, S. & Nicklas, W. J. J. Neurochem. 38, 509–518 (1982).
Monaghan, D. T. & Cotman, C. W. Brain Res. 252, 91–100 (1982).
Garthwaite, J. Neuroscience 7, 2491–2497 (1982).
About this article
Cite this article
Garthwaite, J., Garthwaite, G. The mechanism of kainic acid neurotoxicity. Nature 305, 138–140 (1983). https://doi.org/10.1038/305138a0
European Archives of Oto-Rhino-Laryngology (1990)
The toxin kainic acid: a study of avian nerve and glial cell response utilizing tritiated kainic acid and electron microscopic autoradiography
Acta Neuropathologica (1988)
Influence of the plasma glucose level on brain damage after systemic kainic acid injection in the rat
Acta Neuropathologica (1986)